Libo Wang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Chronic Kidney Disease

Prognostic Factors

Top Venues

Journal of cellular and molecular medicine

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqing Ren, Zongao Cai, Chunguang Guo, Yuyuan Zhang, Hui Xu, Long Liu, Libo Wang, Yuhao Ba, Shutong Liu, Guojun Zhang, Zaoqu Liu, Xin-Wei Han
Associations Between Life's Essential 8 and Chronic Kidney Disease. Journal of the American Heart Association (2023)
Libo Wang, Zaoqu Liu, Ruopeng Liang, Weijie Wang, Rongtao Zhu, Jian Li, Zhe Xing, Siyuan Weng, Xin-Wei Han, Yu-Ling Sun
Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. eLife 11 (2022)
Libo Wang, Zaoqu Liu, Long Liu, Chunguang Guo, Dechao Jiao, Lifeng Li, Jie Zhao, Xin-Wei Han, Yu-Ling Sun
CELF2 is a candidate prognostic and immunotherapy biomarker in triple-negative breast cancer and lung squamous cell carcinoma: A pan-cancer analysis. Journal of cellular and molecular medicine 25 (15) (2021)
Zaoqu Liu, Taoyuan Lu, Yanli Wang, Dechao Jiao, Zhaonan Li, Libo Wang, Long Liu, Chunguang Guo, Yanan Zhao, Xin-Wei Han
Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer. Journal of cellular and molecular medicine 25 (14) (2021)
Zaoqu Liu, Libo Wang, Chunguang Guo, Long Liu, Dechao Jiao, Zhenqiang Sun, Kunpeng Wu, Yanan Zhao, Xin-Wei Han
TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer. Journal of cellular and molecular medicine 25 (7) (2021)